Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rik is the only one who is making money with his salary kinda like fox in charge of the hen house.If something done soon his dream job is going to go away.
Realization!!!
It's a penny stock I guess
Does anyone think that this has a chance of doing anything anymore
If you don't believe this country is about to take opiates off market watch the latest <LAST WEEK WITH JON OLIVER> alot of truth coming out about opiates which should be good for NPHC
what's up!
YOU KNOW SOONER OR LATER BORROWING FROM PETER TO PAY PAUL AND THEN VICE VERSA WILL COME TO A END AND WHEN IT DOES WHO IS LEFT HOLDING THE SACK. YEP THANK YOU !!!!!
I mean really it is amazing they still have a company yet.Talk about beating a dead dog,just let it go and find some other people to fool with something else.
and the bleeding continues
I know I going to sound like Mr.O but something is going on
Most do
Remember, the glass is half full
REALLY !
lots of volume wonder why
JUNK
words,words,words show me the money!
Oh, what is that I'm holding I think it is a bag (wow)
Is this the bottom? I guess we'll find out.
Yes it will be more successful if they spend some money on marketing unlike they did in the U.S.
Not to be a negative Nelly but seen this before when it comes to this stock
maybe this week
please show us the money
It is a penny stock. DUH
We all thought we be paying higher taxes
That is what I was talking about been here before I hope everything works out
I've been part of this company for long time .IF is big for this start up I hope the best
THE STORM IS UPON US
Education Images | UIG | Getty Images
Chicago filed a lawsuit against five major producers of pharmaceutical products on Tuesday, accusing the group of concealing the risks associated with certain painkillers and seeking to recover nearly $10 million in prescription costs.
Alleging that drugmakers "should never place its desire for profits above the health and well-being of its customers," the city said that the companies knew for years that certain pain-alleviating drugs were addictive and could prove debilitating in the long-term.
The five companies named in the suit include Actavis, Endo Health Solutions, Janssen Pharmaceuticals —a unit of Johnson & Johnson, Purdue Pharma and Cephalon, a division of generic drug giant Teva.
The lengthy suit, filed in a Cook County circuit court, alleges that the cohort of companies misused their dominance to broaden the market for "opium-like painkillers" called opoids. These prescription drugs included top-shelf brand names such as OxyContin and Percocet, as well as a clutch of generics.
The drug makers "spent millions of dollars funding, assisting and encouraging doctors and front groups" to promote the drugs and broaden their reach among users afflicted with chronic pain, Chicago says. The city seeks to recover at least some of the $9.5 million it paid to fill 400,000 prescriptions for these drugs since 2008, as well as compensatory damages, penalties and legal costs.
The effort to flood the market was "wildly successful. The United States is now awash in opiods," the suit said, citing data showing that more than 250 million prescriptions for the narcotic were filled in 2010 and generating more than $8 billion in revenue during that year. According to figures, the U.S. represents 80 percent of the global opoid market and 99 percent of the world's hydrocodone supply, the city contends.
The suit contends that the drugs have ramped up addiction that has become a scourge in Chicago and other major cities.
Robyn Frenze, a spokesperson for Janssen, said in a statement e-mailed to CNBC that the company "is committed to ethical business practices and responsible promotion, prescribing and use of all our medications. We're currently reviewing the complaint."
Taking from a long time investor of this stock still alot of if's to be resolve yet but talk is cheap .Hope they go threw with it this time only time will tell.
THE CALM BEFORE THE STORM
THANK YOU! YOUR SO RIGHT
I know DrinkingtheKoolAid dude I used the product yes it works very well but besides the investors who else knows.I know everybody knows it but, management really sucks and if they were try to kill this product they doing a good job. WOW
Is this because ????
DrinkingtheKoolAid DUDE you said 2015 really, don't think so
The sky is falling the sky is falling. Head for cover
Aren't we all
THE BEGINNING OF THE END OR THE END OF THE BEGINNING, I GUESS ONLY TIME WILL TELL